116 related articles for article (PubMed ID: 28367263)
1. Melasma Associated with Topical Estrogen Cream.
Snyder A; Schiechert RA; Zaiac MN
J Clin Aesthet Dermatol; 2017 Feb; 10(2):57-58. PubMed ID: 28367263
[TBL] [Abstract][Full Text] [Related]
2. Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
Cohen PR
Med Hypotheses; 2017 Apr; 101():1-5. PubMed ID: 28351480
[TBL] [Abstract][Full Text] [Related]
3. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula.
Kasraee B; Mansouri P; Farshi S
J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063
[TBL] [Abstract][Full Text] [Related]
4. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
5. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
6. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor expression in melasma: results from facial skin of affected patients.
Lieberman R; Moy L
J Drugs Dermatol; 2008 May; 7(5):463-5. PubMed ID: 18505139
[TBL] [Abstract][Full Text] [Related]
8. The role of oligomenorrhea in melasma.
Mahjour M; Khoushabi A; Feyzabadi Z
Med Hypotheses; 2017 Jul; 104():1-3. PubMed ID: 28673563
[TBL] [Abstract][Full Text] [Related]
9. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients.
Sarkar R; Bhalla M; Kanwar AJ
Dermatology; 2002; 205(3):249-54. PubMed ID: 12399672
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
Torok HM
Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
[TBL] [Abstract][Full Text] [Related]
12. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
13. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
[TBL] [Abstract][Full Text] [Related]
15. Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study.
Nofal A; Ibrahim AM; Nofal E; Gamal N; Osman S
J Cosmet Dermatol; 2019 Feb; 18(1):263-270. PubMed ID: 30146802
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
[TBL] [Abstract][Full Text] [Related]
17. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial.
Griffiths CE; Finkel LJ; Ditre CM; Hamilton TA; Ellis CN; Voorhees JJ
Br J Dermatol; 1993 Oct; 129(4):415-21. PubMed ID: 8217756
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.
Lyons A; Stoll J; Moy R
J Drugs Dermatol; 2018 Sep; 17(9):970-973. PubMed ID: 30235384
[TBL] [Abstract][Full Text] [Related]
19. Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.
Keeling J; Cardona L; Benitez A; Epstein R; Rendon M
Cutis; 2008 Feb; 81(2):179-83. PubMed ID: 18441773
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
